Trial intelligence / Profile preview

Dexmedetomidine for Lung Aeration in Thoracic Surgery

NCT06502002Completed

Sponsor
Brigham and Women's Hospital
Start
Aug 2024
Primary completion
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in postoperative pulmonary complications (PPC) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Lung aeration score measured by ultrasound at 2 days. Started Aug 2024; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pulmonary complications (PPC)

Beyond the preview

Go deeper on NCT06502002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06502002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call